All issues
Volume 52 (2006)
- Issue 3 Pages 397-
- Issue 2 Pages 143-
- Issue 1 Pages 19-
Predecessor
Volume 52, Issue 1
Displaying 1-7 of 7 articles from this issue
- |<
- <
- 1
- >
- >|
-
Simon Finfer2006 Volume 52 Issue 1 Pages 19-25
Published: March 10, 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (788K) -
Hitoshi Okazaki2006 Volume 52 Issue 1 Pages 26-35
Published: March 10, 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (1347K) -
EXPERIENCE WITH TYPE O BLOOD USAGE IN AN EMERGENCY ROOMNoriko Takahashi, Makoto Kashimura, Tomomi Kyono, Keiko Matsuno, Reiko ...2006 Volume 52 Issue 1 Pages 36-43
Published: March 10, 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSTo prevent delays in transfusion and the development of hemolytic transfusion reactions at the emergency room of a local hospital, we implemented a Type O blood usage program for life-threatening bleeding patients in August 2001 according to Japanese government guidelines for transfusion. To better understand actual conditions for urgent blood transfusion before and after implementation of this program, we surveyed the time between ordering to the start of transfusion, shock index at the start of transfusion, total volume of transfused blood, causes of death, irradiation of blood, side effects, and reasonable adaptation of transfusion. Results showed the time between ordering to the start of transfusion shortened to 9.3 minutes from 62.2 minutes after implementation. There was no case in which non-irradiated blood unit, was transfused, nor of incompatible blood transfusion following cross matching. Further, there was no increase in workload following implementation of the Type O blood usage program. In conclusion, Type O blood usage programs can dramatically save time between ordering to the start of transfusion. However, they carry risks such as Rh-positive blood transfusion to Rh-negative patients (about 0.5%) and antigen-positive blood transfusion to patients positive for irregular antibodies (about 1.3%). Adaptation of this transfusion must be carefully controlled. All patients receiving type O blood transfusion should be investigated for suitability after transfusion.View full abstractDownload PDF (4680K) -
Sadamitsu Yamamoto, Tadashi Kamiya, Hitoshi Shibata, Yoshiaki Maeda, K ...2006 Volume 52 Issue 1 Pages 44-51
Published: March 10, 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSWe evaluated the feasibility and safety of red cell collection by apheresis technology. Red cells corresponding to 600ml of whole blood were collected with two types of apheresis machine (Trima and CCS). Healthy male donors whose (circulating) blood volume was 4, 100ml or more were entered into the trial. Mean time for the entire process was 32.4min. All procedures were completed without interruption, although one case of vaso-vagal reaction was noted during collection. No sign of serious side effects was reported after collection. Red cell counts and hemoglobin values of the donors recovered to the baseline 2-3 months after collection, although serum ferritin remained at 64.4% of predonation values after 6 months.
It was concluded that red cell collection by apheresis technology equivalent to 600ml of whole blood is feasible and safe. However, a large scale clinical trial will be necessary to affirm the safety of this procedure.View full abstractDownload PDF (2470K) -
Shin Chiyoda, Hidetaka Oda, Tamaka Kotani, Eisuke Kusaba, Toshiki Kusa ...2006 Volume 52 Issue 1 Pages 52-56
Published: March 10, 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSNagasaki Prefecture is a highly endemic area for hepatitis B virus (HBV). In recent years, we have identified a decrease in the incidence of positivity for hepatitis B surface antigen (HBsAg). In 1985, the Government of Japan started a nationwide prevention program for mother-to-infant infection by HBV. As blood donor is acceptable from age 16, a portion of the people who owed this program became to age with approval of blood donation. We screened 291, 587 serum samples from voluntary blood donors (170, 366 males and 121, 221 females) between 16 and 69 years of age who first visited Nagasaki and Sasebo Red Cross Blood Center from June 1990 to December 2004.
The positive rate for HBsAg among blood donors by year of birth decreased from 1.67 to 0% over the years 1929 to 1988 (test of trend; p<0.001).
No donor born from 1986 to 1988 was positive, although a decrease in the positive rate was recognized before 1985. This may be because in 1985, the Government of Japan started a prevention program for mother-to-infant infection by HBV. Shiraki has reported that this program was very effective. The present study involving the analysis of data among blood donors provides further evidence for the high efficacy of this program.View full abstractDownload PDF (611K) -
2006 Volume 52 Issue 1 Pages 115-116
Published: March 10, 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (165K) -
2006 Volume 52 Issue 1 Pages 117
Published: 2006
Released on J-STAGE: March 12, 2010
JOURNAL FREE ACCESSDownload PDF (64K)
- |<
- <
- 1
- >
- >|